Advanced Enzyme Technologies Limited (ADVENZYMES) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs647.13 Million ≈ $7.00 Million USD) by net assets (Rs15.34 Billion ≈ $165.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ADVENZYMES net asset quality index to measure how much of total assets are equity-financed.
Advanced Enzyme Technologies Limited - Cash Flow Conversion Efficiency Trend (2008–2026)
This chart illustrates how Advanced Enzyme Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Advanced Enzyme Technologies Limited (ADVENZYMES) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Advanced Enzyme Technologies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Marine Electricals (India) Limited
NSE:MARINE
|
0.057x |
|
Huayang Intelligent Co Ltd
SHE:301502
|
N/A |
|
Guggenheim Taxable Municipal Managed Duration Trust
NYSE:GBAB
|
0.026x |
|
Kailong High Technology Co. Ltd.
SHE:300912
|
N/A |
|
Sofwave Medical Ltd
TA:SOFW
|
-0.014x |
|
Lumina Gold Corp
V:LUM
|
0.070x |
|
Bafang Yunji Intl Co Ltd
TW:2753
|
0.123x |
|
Izmir Demir Celik Sanayi AS
IS:IZMDC
|
-0.021x |
Annual Cash Flow Conversion Efficiency for Advanced Enzyme Technologies Limited (2008–2026)
The table below shows the annual cash flow conversion efficiency of Advanced Enzyme Technologies Limited from 2008 to 2026. For the full company profile with market capitalisation and key ratios, see Advanced Enzyme Technologies Limited (ADVENZYMES) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs16.83 Billion ≈ $182.02 Million |
Rs1.73 Billion ≈ $18.66 Million |
0.103x | +0.99% |
| 2025-03-31 | Rs14.69 Billion ≈ $158.83 Million |
Rs1.49 Billion ≈ $16.12 Million |
0.102x | -1.54% |
| 2024-03-31 | Rs13.71 Billion ≈ $148.28 Million |
Rs1.41 Billion ≈ $15.29 Million |
0.103x | -5.67% |
| 2023-03-31 | Rs12.84 Billion ≈ $138.88 Million |
Rs1.40 Billion ≈ $15.18 Million |
0.109x | +1.93% |
| 2022-03-31 | Rs11.40 Billion ≈ $123.33 Million |
Rs1.22 Billion ≈ $13.23 Million |
0.107x | -32.14% |
| 2021-03-31 | Rs10.31 Billion ≈ $111.47 Million |
Rs1.63 Billion ≈ $17.62 Million |
0.158x | -2.71% |
| 2020-03-31 | Rs8.67 Billion ≈ $93.81 Million |
Rs1.41 Billion ≈ $15.24 Million |
0.162x | -10.95% |
| 2019-03-31 | Rs7.05 Billion ≈ $76.22 Million |
Rs1.29 Billion ≈ $13.90 Million |
0.182x | -8.51% |
| 2018-03-31 | Rs5.82 Billion ≈ $62.91 Million |
Rs1.16 Billion ≈ $12.54 Million |
0.199x | -12.24% |
| 2017-03-31 | Rs4.73 Billion ≈ $51.10 Million |
Rs1.07 Billion ≈ $11.61 Million |
0.227x | -34.12% |
| 2016-03-31 | Rs2.83 Billion ≈ $30.65 Million |
Rs977.51 Million ≈ $10.57 Million |
0.345x | +38.92% |
| 2015-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs537.31 Million ≈ $5.81 Million |
0.248x | -23.58% |
| 2014-03-31 | Rs1.71 Billion ≈ $18.50 Million |
Rs555.67 Million ≈ $6.01 Million |
0.325x | +31.07% |
| 2013-03-31 | Rs1.66 Billion ≈ $17.94 Million |
Rs411.24 Million ≈ $4.45 Million |
0.248x | -73.06% |
| 2012-03-31 | Rs984.09 Million ≈ $10.64 Million |
Rs905.46 Million ≈ $9.79 Million |
0.920x | +4950.18% |
| 2011-03-31 | Rs645.35 Million ≈ $6.98 Million |
Rs11.76 Million ≈ $127.15K |
0.018x | -91.07% |
| 2010-03-31 | Rs489.29 Million ≈ $5.29 Million |
Rs99.82 Million ≈ $1.08 Million |
0.204x | -30.61% |
| 2009-03-31 | Rs379.81 Million ≈ $4.11 Million |
Rs111.66 Million ≈ $1.21 Million |
0.294x | +56.82% |
| 2008-03-31 | Rs319.19 Million ≈ $3.45 Million |
Rs59.84 Million ≈ $647.15K |
0.187x | -- |
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more